Apremilast for the treatment of a liver disease or a liver function abnormality

作者: Randall Stevens , Douglas Hough

DOI:

关键词: ApremilastGastroenterologyAbnormalityLiver diseaseMedicineInternal medicineTreatment regimenLiver function

摘要: Methods of treating, managing or preventing liver disease are disclosed. Specific methods encompass the administration apremilast, alone in combination with additional active agents treatment regimens.

参考文章(157)
W. Baehr, M.J. Devlin, M.L. Applebury, Isolation and characterization of cGMP phosphodiesterase from bovine rod outer segments. Journal of Biological Chemistry. ,vol. 254, pp. 11669- 11677 ,(1979) , 10.1016/S0021-9258(19)86536-5
E E Lower, R P Baughman, S A Strohofer, J Buchsbaum, Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. Journal of Laboratory and Clinical Medicine. ,vol. 115, pp. 36- 42 ,(1990)
Richard A. Partyka, Ronnie R. Crenshaw, 1,2,3-Thiadiazole amides ,(1977)
Christopher M. Norris, Flexibility : principles & practice A & C Black. ,(1994)
Stephen Byrn, Ralph Pfeiffer, Michael Ganey, Charles Hoiberg, Guirag Poochikian, Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations Pharmaceutical Research. ,vol. 12, pp. 945- 954 ,(1995) , 10.1023/A:1016241927429
Dwight MacDonald, Carole Lepine, Helene Perrier, Robert N. Young, Andre Giroux, Yongxin Han, Aryl thiophene derivatives as PDE IV inhibitors ,(1998)
Ulrich Dr. Niewöhner, Matthias Dr. Schramm, Elisabeth Dr. Perzborn, Helmuth Dr. Schütz, Erwin Dr. Bischoff, 2,9-disubstituted purin-6-ones ,(1996)
Ulrich Dr. Niewöhner, Matthias Dr. Schramm, Erwin Dr. Bischoff, Elisabeth Dr. Perzborn, Helmuth Dr. Schütz, 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones ,(1996)